Unknown

Dataset Information

0

Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.


ABSTRACT:

Introduction//background

The lack of standardization of the currently used commercial anti-rubella IgG antibody assays leads to frequent misinterpretation of results for samples with low/equivocal antibody concentration. The use of alternative approaches in rubella serology could add new information leading to a fuller understanding of rubella protective immunity and neutralizing antibody response after vaccination.

Methods

We applied microarray technology to measure antibodies to all rubella virus proteins in 75 high and 75 low rubella virus-specific antibody responders after two MMR vaccine doses. These data were used in multivariate penalized logistic regression modeling of rubella-specific neutralizing antibody response after vaccination.

Results

We measured antibodies to all rubella virus structural proteins (i.e., the glycoproteins E1 and E2 and the capsid C protein) and to the non-structural protein P150. Antibody levels to each of these proteins were: correlated with the neutralizing antibody titer (p<0.006); demonstrated differences between the high and the low antibody responder groups (p<0.008); and were components of the model associated with/predictive of vaccine-induced rubella virus-specific neutralizing antibody titers (misclassification error = 0.2).

Conclusion

Our study supports the use of this new technology, as well as the use of antibody profiles/patterns (rather than single antibody measures) as biomarkers of neutralizing antibody response and correlates of protective immunity in rubella virus serology.

SUBMITTER: Haralambieva IH 

PROVIDER: S-EPMC5690594 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.

Haralambieva Iana H IH   Gibson Michael J MJ   Kennedy Richard B RB   Ovsyannikova Inna G IG   Warner Nathaniel D ND   Grill Diane E DE   Poland Gregory A GA  

PloS one 20171116 11


<h4>Introduction//background</h4>The lack of standardization of the currently used commercial anti-rubella IgG antibody assays leads to frequent misinterpretation of results for samples with low/equivocal antibody concentration. The use of alternative approaches in rubella serology could add new information leading to a fuller understanding of rubella protective immunity and neutralizing antibody response after vaccination.<h4>Methods</h4>We applied microarray technology to measure antibodies to  ...[more]

Similar Datasets

2017-09-23 | GSE104148 | GEO
| PRJNA411822 | ENA
| S-EPMC4249927 | biostudies-literature
| S-EPMC6754597 | biostudies-literature
| S-EPMC4679650 | biostudies-literature